Efficacy of Olaratumab and Rechallenge With Doxorubicin in Anthracycline Pretreated, Advanced Soft Tissue Sarcoma Patients. An Exploratory Phase-II Study
Phase of Trial: Phase II
Latest Information Update: 04 Feb 2019
Price : $35 *
At a glance
- Drugs Olaratumab (Primary) ; Dexrazoxane; Doxorubicin
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms OlaReDo
- 30 Jan 2019 Status changed from recruiting to suspended.
- 02 Jan 2019 Status changed from not yet recruiting to recruiting.
- 23 Aug 2018 New trial record